中国新条件审批流程的进展和挑战:2018年至2021年的综合分析
Jinlian Li1, Haoyang Wang1, Yanzhao Hua1
1Institute of Regulatory Science for Medical Products, China Pharmaceutical University, Nanjing, Jiangsu Province, China.
Clinical therapeutics
|October 8, 2023
概括
中国中国中国中国.
科学领域:
- 制药科学 制药科学
- 临床药理学 临床药理学
- 监管科学 监管科学
背景情况:
- 中国在2017年实施了条件药物批准,以加快获得所需药物的机会.
- 这一过程旨在平衡快速审查与确保药物的安全性和有效性.
研究的目的:
- 评估中国条件药物批准程序的实施情况.
- 确定这一监管途径的挑战和未来方向.
主要方法:
- 来自中国药物评估中心 (2018-2021) 的药物技术审查文件的分析.
- 检查关键临床试验数据,营销后研究要求和条件批准药物的结果.
主要成果:
- 有条件批准的药物有50种 (2018-2021年),主要是瘤学药物 (80%).
- 营销前试验经常使用单臂设计,而营销后试验则倾向于随机对照试验.
- 使用无进展生存 (PFS) 或总生存 (OS) 终点的瘤学药物观察到显著的疗效,但一些反应率 (RR) 试验显示效果有限.
- 安全数据 (不良事件,严重不良事件) 显示了广泛的变化.
- 在营销后研究中指出了方法问题和缺乏明确的过渡标准.
结论:
- 有条件的批准加速了患者获得关键疗法的机会.
- 需要改进初步批准的证据评估,以及营销后研究的设计和监督,以确保可靠的数据生成和及时的全面批准.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Administration and Therapy Phases: Overview
493
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
493
Drug Control Governance: Regulatory Bodies and Their Impact
170
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
170
Global Regulatory Systems
30
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
30


